ID
45565
Beskrivning
Principal Investigator: Anand Swaroop, PhD, National Eye Institute, National Institutes of Health, Bethesda, MD, USA MeSH: https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000684 Age-related Macular Degeneration (AMD) is a leading cause of incurable blindness in people over the age of 65. AMD is a late-onset multi-factorial neurodegenerative disease and its pathogenesis involves interaction of genetic and environmental factors. Several chromosomal regions have been associated with AMD susceptibility through linkage analysis (Swaroop et al., 2009). More recent studies provide strong evidence that variants within the CFH gene cluster on chromosome 1 and at/near LOC387715/ARMS2 on chromosome 10 are strongly associated with the disease. Variants at other genes including C2/BF, C3, CFI and APOE4, also contribute to AMD susceptibility. Our primary goals are to identify genetic variants and haplotypes that are associated with AMD. The underlying hypothesis is that DNA variation(s) in multiple genetic susceptibility loci will predispose individuals to AMD pathogenesis, and comparison of DNA of cases and controls should identify these susceptibility variants. Our studies are focused on the genetic analysis of advanced AMD and should provide novel insights into disease diagnosis, progression and pathology. We have assembled a collaborative group of researchers from the University of Michigan, Mayo Clinic, University of Pennsylvania, and the AREDS group including National Eye Institute intramural investigators, who collected clinical data and DNA from a large number of patients affected with AMD and from unaffected controls. The primary source of funding was National Eye Institute. Study 1: To identify genetic variants and haplotypes that are associated with AMD, we submitted and obtained usable genotyping data on 2185 patients and 1155 controls from the Center for Inherited Disease Research (CIDR). Study 2: To identify rare coding variants associated with a large increase in risk of AMD, 10 candidate loci spanning 57 genes were sequenced in 2,335 cases and 789 controls. Probes were designed to capture 96.5% of the coding sequence and 35% of total locus sequence, generating an average 123Mb of on-target sequence per individual at 127x average depth. *Substudies:* - phs000182 AMD-MMAP Cohort Study: A Joint Genome-Wide Asscociation Study - phs000246 Fuchs' Corneal Dystrophy GWAS - phs000457 MMAP Methylation in AMD - phs000685 Age-Related Macular Degeneration Targeted Sequencing Study
Länk
Nyckelord
Versioner (1)
- 2023-01-13 2023-01-13 - Chiara Middel
Rättsinnehavare
Anand Swaroop, PhD, National Eye Institute, National Institutes of Health, Bethesda, MD, USA
Uppladdad den
13 januari 2023
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
dbGaP phs000684 Age related Macular Degeneration - MMAP Cohort: Association and Sequencing Studies
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- The data set contains variables used to identify study participants with (case) or without (control) diagnosis of AMD (e.g. presence of geographic atrophy, neovasularization, large drusen, n=2 variables), their smoking habits (n=3 variables), and basic sociodemographic (i.e. age, gender) and administrative information. In version 3, the study became a substudy of phs000684 .
- CIDR_AMD Subject - Consent Form specifies the consent form used.
- CIDR_AMD Sample - Subject Mapping
- The dataset provides information about presence/absence of a diagnosis of Fuchs' Corneal Dystrophy in participants.
- CIDR_AMD Sample - Attribute Information
- Sample - Attribute information of the AMD - MMAP DNA methylation study.
- Subject - Consent information of the MMAP cohort association and sequence studies.
- Subject-Sample Mapping information of the MMAP cohort association and sequence studies.
- Subject-Sample Mapping information of the AMD - MMAP DNA methylation study.
- Subject-Sample Mapping information of the AMD - MMAP targeted sequencing study.
- Sample - Attribute information of the AMD - MMAP targeted sequencing study.
Similar models
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- The data set contains variables used to identify study participants with (case) or without (control) diagnosis of AMD (e.g. presence of geographic atrophy, neovasularization, large drusen, n=2 variables), their smoking habits (n=3 variables), and basic sociodemographic (i.e. age, gender) and administrative information. In version 3, the study became a substudy of phs000684 .
- CIDR_AMD Subject - Consent Form specifies the consent form used.
- CIDR_AMD Sample - Subject Mapping
- The dataset provides information about presence/absence of a diagnosis of Fuchs' Corneal Dystrophy in participants.
- CIDR_AMD Sample - Attribute Information
- Sample - Attribute information of the AMD - MMAP DNA methylation study.
- Subject - Consent information of the MMAP cohort association and sequence studies.
- Subject-Sample Mapping information of the MMAP cohort association and sequence studies.
- Subject-Sample Mapping information of the AMD - MMAP DNA methylation study.
- Subject-Sample Mapping information of the AMD - MMAP targeted sequencing study.
- Sample - Attribute information of the AMD - MMAP targeted sequencing study.
C0680251 (UMLS CUI [1,2])
C0522476 (UMLS CUI [1,2])
C1536085 (UMLS CUI [1,3])
C0035320 (UMLS CUI [1,4])
C0549177 (UMLS CUI [1,5])
C1260959 (UMLS CUI [1,6])
C1512693 (UMLS CUI [2,1])
C0243095 (UMLS CUI [2,2])
C0205171 (UMLS CUI [2,3])
C0015392 (UMLS CUI [2,4])
C0205394 (UMLS CUI [2,5])
C0015392 (UMLS CUI [2,6])
C1260959 (UMLS CUI [2,7])
C0549661 (UMLS CUI [2,8])
C0009932 (UMLS CUI [3,1])
C0439092 (UMLS CUI [3,2])
C0205451 (UMLS CUI [3,3])
C1719777 (UMLS CUI [3,4])
C0001779 (UMLS CUI [3,5])
C0009932 (UMLS CUI [4,1])
C0700321 (UMLS CUI [4,2])
C1260959 (UMLS CUI [4,3])
C0549661 (UMLS CUI [4,4])
C0205171 (UMLS CUI [4,5])
C0015392 (UMLS CUI [4,6])
C0001779 (UMLS CUI [4,7])
C3887511 (UMLS CUI [1,2])
C0262926 (UMLS CUI [1,3])
C0205082 (UMLS CUI [1,4])
C0730362 (UMLS CUI [1,5])
C3665347 (UMLS CUI [1,6])
C0001779 (UMLS CUI [1,7])
C0680251 (UMLS CUI [2,1])
C0011900 (UMLS CUI [2,2])
C1457887 (UMLS CUI [2,3])
C4282180 (UMLS CUI [2,4])
C3146221 (UMLS CUI [2,5])
C0035304 (UMLS CUI [2,6])
C0680251 (UMLS CUI [3,1])
C0332574 (UMLS CUI [3,2])
C0010957 (UMLS CUI [3,3])
C1274040 (UMLS CUI [3,4])
C1299003 (UMLS CUI [3,5])
C3714660 (UMLS CUI [3,6])
C0035305 (UMLS CUI [3,7])
C0205250 (UMLS CUI [3,8])
C0027092 (UMLS CUI [3,9])
C0008513 (UMLS CUI [3,10])
C1290884 (UMLS CUI [3,11])
C0730291 (UMLS CUI [3,12])
C0205394 (UMLS CUI [3,13])
C0235272 (UMLS CUI [3,14])